However the specificity and sensitivity of current biomarkers, including C-reactive protein (CRP), Procalcitonin (PCT), and Interleukin-6 (IL-6) are limited in this setting [8,9], and recent studies have suggested the use of new biomarkers for sepsis, including analysis of circulating miRNAs [10,11]. This evidence concerns the gene CRP and Sepsis.